MorphoSys AG Profit Margin 2018-2021 | MOR
Current and historical gross margin, operating margin and net profit margin for MorphoSys AG (MOR) over the last 10 years. Profit margin can be defined as the percentage of revenue that a company retains as income after the deduction of expenses. MorphoSys AG net profit margin as of September 30, 2021 is -91.31%.
|MorphoSys AG Annual Profit Margins
|MorphoSys AG Quarterly Profit Margins
||Medical - Biomedical and Genetics
MorphoSys AG is a biopharmaceutical company. It develops treatment for cancer, inflammations and autoimmune diseases. The company's proprietary portfolio consists of MOR208, MOR202, MOR103, MOR106 and MOR107. Its partnered programs lighthouse project includes Tremfya(R) and Gantenerumab. MorphoSys AG is based in Planegg, Germany.